Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization · HackerPapers discussions

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Wed, 02 Dec 2020 18:23:54 GMT

Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - Recently announced a multi-target drug discovery partnership with Genentech: https://www.businesswire.com/news/home/20201019005182/en/Gen...…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Tue, 03 Nov 2020 01:06:10 GMT

Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - Just announced a multi-target drug discovery partnership with Genentech: https://www.businesswire.com/news/home/20201019005182/en/Gen... - We…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Tue, 01 Sep 2020 21:26:28 GMT

Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent AI + software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 03 Aug 2020 16:25:54 GMT

Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent AI + software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Wed, 01 Jul 2020 20:39:30 GMT

Genesis Therapeutics | Burlingame, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook, Google…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 01 Jun 2020 19:22:56 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Fri, 01 May 2020 20:02:34 GMT

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by GenesisTx

Fri, 17 Apr 2020 17:08:35 GMT

This post is nicely written. We are from the Pande Lab @ Stanford and are very supportive of this work being done by Barzilay et al at MIT. We cite each others' papers for good reason. If this type of research interests anyone here, Genesis Therapeutics -- Stanford spinout and a16z-backed -- is hiring! Here is our HN "who's hiring?" post. Join us in using deep learning to discover medicines for patients suffering from devastating diseases. Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Wed, 01 Apr 2020 18:46:15 GMT

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 23 Mar 2020 17:41:57 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite (Flexible WFH) | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 02 Mar 2020 19:32:37 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Small team of excellent software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook, Google, Memsql, Jane Street - Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 03 Feb 2020 22:06:33 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet paper: https://pubs.acs.org/doi/10.1021/acscentsci.8b00507 - Recently raised a $4.1m seed round led by Andreessen Horowitz - Our platform was…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Thu, 02 Jan 2020 21:01:18 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet paper: https://pubs.acs.org/doi/10.1021/acscentsci.8b00507 - Recently raised a $4.1m seed round led by Andreessen Horowitz - Our platform was…

Paper and discussion history. A mention is not an endorsement.

Step Change Improvement in ADMET Prediction with PotentialNet Deep Featurization — mentioned by salt-licker

Mon, 02 Dec 2019 18:29:36 GMT

Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. - Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s acclaimed Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet paper: https://pubs.acs.org/doi/10.1021/acscentsci.8b00507 - Recently raised a $4.1m seed round led by Andreessen Horowitz - Our platform…

Paper and discussion history. A mention is not an endorsement.